LINC02316

Across TCGA pan-cancer cohorts, LINC02316 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02316’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02316 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02316 is over-expressed in tumor.

HNSC and STAD are the cancer types where LINC02316 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02316 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.022	.019	2	view →
STAD	Male	All	+0.030	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02316–HNSC

Open the HNSC breakdown →